{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T04:10:05Z","timestamp":1789531805235,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82372320"],"award-info":[{"award-number":["82372320"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82371810"],"award-info":[{"award-number":["82371810"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National high level hospital clinical research funding"},{"name":"Elite Medical Professionals Project of China-Japan Friendship Hospital","award":["ZRJY2024-BJ04"],"award-info":[{"award-number":["ZRJY2024-BJ04"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"DOI":"10.1186\/s12931-025-03414-3","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T12:46:44Z","timestamp":1764074804000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A serum biomarker-based index for predicting progressive pulmonary fibrosis in patients with anti-synthetase syndrome: the LOCCM index"],"prefix":"10.1186","volume":"26","author":[{"given":"Longyang","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Zong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiran","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingfang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guochun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinglin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"issue":"1","key":"3414_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00321-x","volume":"7","author":"IE Lundberg","year":"2021","unstructured":"Lundberg IE, Fujimoto M, Vencovsky J, Aggarwal R, Holmqvist M, Christopher-Stine L, et al. Idiopathic inflammatory myopathies. Nat Rev Dis Primers. 2021;7(1):87.","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"3414_CR2","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1136\/ard-2023-225284","volume":"83","author":"S Wu","year":"2024","unstructured":"Wu S, Xiao X, Zhang Y, Zhang X, Wang G, Peng Q. Novel endotypes of antisynthetase syndrome identified independent of anti-aminoacyl transfer RNA synthetase antibody specificity that improve prognostic stratification. Ann Rheum Dis. 2024;83(6):775\u201386.","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"3414_CR3","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","volume":"205","author":"G Raghu","year":"2022","unstructured":"Raghu G, Remy-Jardin M, Richeldi L, Thomson CC, Inoue Y, Johkoh T, et al. Idiopathic pulmonary fibrosis (an Update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2022;205(9):e18\u201347.","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"3414_CR4","doi-asserted-by":"publisher","first-page":"4746","DOI":"10.1007\/s00330-023-09439-w","volume":"33","author":"W Wu","year":"2023","unstructured":"Wu W, Collins BF, Gardner GC, Hippe DS, Ho LA, Raghu G, et al. Antisynthetase syndrome-related interstitial lung disease (ASyS-ILD): longitudinal imaging findings. Eur Radiol. 2023;33(7):4746\u201357.","journal-title":"Eur Radiol"},{"issue":"7","key":"3414_CR5","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1007\/s10067-023-06570-3","volume":"42","author":"H Fu","year":"2023","unstructured":"Fu H, Zheng Z, Zhang Z, Yang Y, Cui J, Wang Z, et al. Prediction of progressive pulmonary fibrosis in patients with anti-synthetase syndrome-associated interstitial lung disease. Clin Rheumatol. 2023;42(7):1917\u201329.","journal-title":"Clin Rheumatol"},{"issue":"6","key":"3414_CR6","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1378\/chest.10-0180","volume":"138","author":"GR Connors","year":"2010","unstructured":"Connors GR, Christopher-Stine L, Oddis CV, Danoff SK. Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years? Chest. 2010;138(6):1464\u201374.","journal-title":"Chest"},{"issue":"2","key":"3414_CR7","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1164\/ajrccm.165.2.ats01","volume":"165","author":"S American Thoracic","year":"2002","unstructured":"American Thoracic S, European Respiratory S, American Thoracic Society\/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American thoracic society (ATS), and the European respiratory society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS executive Committee, June 2001. Am J Respir Crit Care Med. 2002;165(2):277\u2013304.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"3414_CR8","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","volume":"188","author":"WD Travis","year":"2013","unstructured":"Travis WD, Costabel U, Hansell DM, King TE Jr., Lynch DA, Nicholson AG, et al. An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188(6):733\u201348.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"3414_CR9","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.autrev.2012.06.006","volume":"12","author":"B Hervier","year":"2012","unstructured":"Hervier B, Devilliers H, Stanciu R, Meyer A, Uzunhan Y, Masseau A, et al. Hierarchical cluster and survival analyses of antisynthetase syndrome: phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity. Autoimmun Rev. 2012;12(2):210\u20137.","journal-title":"Autoimmun Rev"},{"issue":"9","key":"3414_CR10","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1093\/rheumatology\/keq149","volume":"49","author":"T Gono","year":"2010","unstructured":"Gono T, Kawaguchi Y, Satoh T, Kuwana M, Katsumata Y, Takagi K, et al. Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis. Rheumatology (Oxford). 2010;49(9):1713\u20139.","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"3414_CR11","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/art.42308","volume":"75","author":"L Xu","year":"2023","unstructured":"Xu L, You H, Wang L, Lv C, Yuan F, Li J, et al. Identification of three different phenotypes in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis patients: implications for prediction of rapidly progressive interstitial lung disease. Arthritis Rheumatol. 2023;75(4):609\u201319.","journal-title":"Arthritis Rheumatol"},{"key":"3414_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.845988","volume":"13","author":"Y Zuo","year":"2022","unstructured":"Zuo Y, Ye L, Chen F, Shen Y, Lu X, Wang G, et al. Different multivariable risk factors for rapid progressive interstitial lung disease in anti-MDA5 positive dermatomyositis and anti-synthetase syndrome. Front Immunol. 2022;13:845988.","journal-title":"Front Immunol"},{"issue":"9","key":"3414_CR13","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/S2213-2600(21)00017-5","volume":"9","author":"P Spagnolo","year":"2021","unstructured":"Spagnolo P, Ryerson CJ, Putman R, Oldham J, Salisbury M, Sverzellati N, et al. Early diagnosis of fibrotic interstitial lung disease: challenges and opportunities. Lancet Respir Med. 2021;9(9):1065\u201376.","journal-title":"Lancet Respir Med"},{"issue":"4","key":"3414_CR14","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.chest.2023.11.037","volume":"165","author":"AG Brixey","year":"2024","unstructured":"Brixey AG, Oh AS, Alsamarraie A, Chung JH. Pictorial review of fibrotic interstitial lung disease on high-resolution CT scan and updated classification. Chest. 2024;165(4):908\u201323.","journal-title":"Chest"},{"key":"3414_CR15","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.pharmthera.2019.05.014","volume":"202","author":"AS Jee","year":"2019","unstructured":"Jee AS, Sahhar J, Youssef P, Bleasel J, Adelstein S, Nguyen M, et al. Review. Serum biomarkers in idiopathic pulmonary fibrosis and systemic sclerosis associated interstitial lung disease - frontiers and horizons. Pharmacol Ther. 2019;202:40\u201352.","journal-title":"Pharmacol Ther"},{"issue":"2","key":"3414_CR16","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1136\/annrheumdis-2020-217455","volume":"80","author":"AM Hoffmann-Vold","year":"2021","unstructured":"Hoffmann-Vold AM, Allanore Y, Alves M, Brunborg C, Airo P, Ananieva LP, et al. Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database. Ann Rheum Dis. 2021;80(2):219\u201327.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"3414_CR17","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1164\/rccm.202308-1445LE","volume":"208","author":"D Huang","year":"2023","unstructured":"Huang D, Li Y, Liu Y. Tacrolimus and the treatment of pulmonary fibrosis. Am J Respir Crit Care Med. 2023;208(11):1241\u20132.","journal-title":"Am J Respir Crit Care Med"},{"key":"3414_CR18","doi-asserted-by":"crossref","unstructured":"Miadlikowska E, Milkowska-Dymanowska J, Bialas AJ, Makowska JS, Lewandowska-Polak A, Lacwik P, et al. Predictors of one-year interstitial lung disease progression in patients with interstitial pneumonia with autoimmune features: a single-center, prospective study. Pol Arch Intern Med. 2025;135(10):17115.","DOI":"10.20452\/pamw.17115"},{"key":"3414_CR19","doi-asserted-by":"crossref","unstructured":"Hambly N, Farooqi MM, Dvorkin-Gheva A, Donohoe K, Garlick K, Scallan C, et al. Prevalence and characteristics of progressive fibrosing interstitial lung disease in a prospective registry. Eur Respir J. 2022;60(4):2102571.","DOI":"10.1183\/13993003.02571-2021"},{"issue":"2","key":"3414_CR20","doi-asserted-by":"publisher","first-page":"e12084","DOI":"10.1002\/pul2.12084","volume":"12","author":"JL Bryan","year":"2022","unstructured":"Bryan JL, Matar R, Raviprasad A, Kuteyeva V, Milla E, Begateri O, et al. Echocardiographic characteristics of patients with antisynthetase syndrome. Pulm Circ. 2022;12(2):e12084.","journal-title":"Pulm Circ"},{"issue":"1","key":"3414_CR21","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s11604-020-01030-3","volume":"39","author":"E Baratella","year":"2021","unstructured":"Baratella E, Marrocchio C, Cifaldi R, Santagiuliana M, Bozzato AM, Crivelli P, et al. Interstitial lung disease in patients with antisynthetase syndrome: a retrospective case series study. Jpn J Radiol. 2021;39(1):40\u20136.","journal-title":"Jpn J Radiol"},{"issue":"1","key":"3414_CR22","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1136\/annrheumdis-2012-201800","volume":"73","author":"R Aggarwal","year":"2014","unstructured":"Aggarwal R, Cassidy E, Fertig N, Koontz DC, Lucas M, Ascherman DP, et al. Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients. Ann Rheum Dis. 2014;73(1):227\u201332.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"3414_CR23","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.resinv.2019.12.003","volume":"58","author":"N Aiko","year":"2020","unstructured":"Aiko N, Yamakawa H, Iwasawa T, Takemura T, Okudela K, Kitamura H, et al. Clinical, radiological, and pathological features of anti-asparaginyl tRNA synthetase antibody-related interstitial lung disease. Respir Investig. 2020;58(3):196\u2013203.","journal-title":"Respir Investig"},{"key":"3414_CR24","doi-asserted-by":"publisher","DOI":"10.1177\/2040622320968417","volume":"11","author":"Y Ge","year":"2020","unstructured":"Ge Y, Li S, Li S, He L, Lu X, Wang G. Interstitial lung disease is a major characteristic of anti-KS associated ant-synthetase syndrome. Ther Adv Chronic Dis. 2020;11:2040622320968417.","journal-title":"Ther Adv Chronic Dis"},{"issue":"22","key":"3414_CR25","doi-asserted-by":"publisher","first-page":"3409","DOI":"10.2169\/internalmedicine.9239-21","volume":"61","author":"N Oda","year":"2022","unstructured":"Oda N, Taniguchi A, Aokage T, Senoo S, Nagashima K, Mitani R, et al. Fulminant respiratory failure caused by anti-asparaginyl tRNA synthetase (Anti-KS) antibody syndrome-related interstitial lung disease. Intern Med. 2022;61(22):3409\u201314.","journal-title":"Intern Med"},{"key":"3414_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1404828","volume":"15","author":"C Shao","year":"2024","unstructured":"Shao C, Xia N, Zhen Y, Zhang X, Yan N, Guo Q. Prognostic significance of natural killer cell depletion in predicting progressive fibrosing interstitial lung disease in idiopathic inflammatory myopathies. Front Immunol. 2024;15:1404828.","journal-title":"Front Immunol"},{"key":"3414_CR27","doi-asserted-by":"crossref","unstructured":"Zanatta E, Cocconcelli E, Castelli G, Giraudo C, Fraia AS, De Zorzi E, et al. Interstitial lung disease with and without progressive fibrosing phenotype in patients with idiopathic inflammatory myopathies: data from a large multicentric cohort. RMD Open. 2023;9(3):e003121.","DOI":"10.1136\/rmdopen-2023-003121"},{"issue":"5","key":"3414_CR28","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1111\/1756-185X.14664","volume":"26","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Zhang C, Su H, Yin X, Liu X, Hou H, et al. Predictive factors for progressive fibrosing interstitial lung disease in anti-synthetase syndrome. Int J Rheum Dis. 2023;26(5):885\u201394.","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"3414_CR29","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2024.2406439","volume":"56","author":"Z Cen","year":"2024","unstructured":"Cen Z, Cen T, Ding Q, Zhang Y, Tang P, Lv C, et al. Outcomes and predictors of progression in progressive pulmonary fibrosis. Ann Med. 2024;56(1):2406439.","journal-title":"Ann Med"},{"issue":"18","key":"3414_CR30","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","volume":"381","author":"KR Flaherty","year":"2019","unstructured":"Flaherty KR, Wells AU, Cottin V, Devaraj A, Walsh SLF, Inoue Y, et al. Nintedanib in progressive fibrosing interstitial lung diseases. N Engl J Med. 2019;381(18):1718\u201327.","journal-title":"N Engl J Med"},{"key":"3414_CR31","doi-asserted-by":"crossref","unstructured":"Wijsenbeek M, Swigris JJ, Inoue Y, Kreuter M, Maher TM, Suda T, et al. Effects of nintedanib on symptoms in patients with progressive pulmonary fibrosis. Eur Respir J. 2024;63(2):2300752.","DOI":"10.1183\/13993003.00752-2023"},{"issue":"8","key":"3414_CR32","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1183\/09031936.96.09081736","volume":"9","author":"M Drent","year":"1996","unstructured":"Drent M, Cobben NA, Henderson RF, Wouters EF, van Dieijen-Visser M. Usefulness of lactate dehydrogenase and its isoenzymes as indicators of lung damage or inflammation. Eur Respir J. 1996;9(8):1736\u201342.","journal-title":"Eur Respir J"},{"key":"3414_CR33","doi-asserted-by":"crossref","unstructured":"Araujo M, Beltrao M, Sokhatska O, Melo N, Caetano Mota P, Bastos HN, et al . Serum metalloproteinase-7 as a biomarker of progressive pulmonary fibrosis. ERJ Open Res. 2024;10(6):00553\u20132024.","DOI":"10.1183\/23120541.00553-2024"},{"issue":"12","key":"3414_CR34","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1164\/rccm.202107-1769OC","volume":"205","author":"PL Molyneaux","year":"2022","unstructured":"Molyneaux PL, Fahy WA, Byrne AJ, Braybrooke R, Saunders P, Toshner R, et al. CYFRA 21-1 Predicts Progression in Idiopathic Pulmonary Fibrosis: A Prospective Longitudinal Analysis of the PROFILE Cohort. Am J Respir Crit Care Med. 2022;205(12):1440\u20138.","journal-title":"Am J Respir Crit Care Med"},{"key":"3414_CR35","doi-asserted-by":"crossref","unstructured":"Clynick B, Corte TJ, Jo HE, Stewart I, Glaspole IN, Grainge C, et al. Biomarker signatures for progressive idiopathic pulmonary fibrosis. Eur Respir J. 2022;59(3):2101181.","DOI":"10.1183\/13993003.01181-2021"},{"issue":"8","key":"3414_CR36","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1164\/rccm.201201-0084OC","volume":"186","author":"RM Kottmann","year":"2012","unstructured":"Kottmann RM, Kulkarni AA, Smolnycki KA, Lyda E, Dahanayake T, Salibi R , et al. Lactic acid is elevated in idiopathic pulmonary fibrosis and induces myofibroblast differentiation via pH-dependent activation of transforming growth factor-beta. Am J Respir Crit Care Med. 2012;186(8):740\u201351.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"3414_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-021-01866-x","volume":"22","author":"DA Newton","year":"2021","unstructured":"Newton DA, Lottes RG, Ryan RM, Spyropoulos DD, Baatz JE. Dysfunctional lactate metabolism in human alveolar type II cells from idiopathic pulmonary fibrosis lung explant tissue. Respir Res. 2021;22(1):278.","journal-title":"Respir Res"},{"issue":"9","key":"3414_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0020251","volume":"2","author":"A Pardo","year":"2005","unstructured":"Pardo A, Gibson K, Cisneros J, Richards TJ, Yang Y, Becerril C, et al. Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis. PLoS Med. 2005;2(9):e251.","journal-title":"PLoS Med"},{"issue":"4","key":"3414_CR39","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/j.1440-1843.2006.00881.x","volume":"11","author":"M Okada","year":"2006","unstructured":"Okada M, Suzuki K, Nakanishi T, Nakashima M. Serum levels of KL-6 are positively correlated with those of CA15-3 in patients with interstitial pneumonia associated with collagen diseases. Respirology. 2006;11(4):509\u201310.","journal-title":"Respirology"},{"issue":"3","key":"3414_CR40","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/1097-0142(19930801)72:3<707::AID-CNCR2820720313>3.0.CO;2-X","volume":"72","author":"P Stieber","year":"1993","unstructured":"Stieber P, Hasholzner U, Bodenmuller H, Nagel D, Sunder-Plassmann L, Dienemann H, et al. CYFRA 21\u2009\u2013\u20091. A new marker in lung cancer. Cancer. 1993;72(3):707\u201313.","journal-title":"Cancer"},{"issue":"1","key":"3414_CR41","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1164\/rccm.200905-0674OC","volume":"182","author":"TM Maher","year":"2010","unstructured":"Maher TM, Evans IC, Bottoms SE, Mercer PF, Thorley AJ, Nicholson AG, et al. Diminished prostaglandin E2 contributes to the apoptosis paradox in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2010;182(1):73\u201382.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"3414_CR42","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1165\/rcmb.2015-0020TR","volume":"53","author":"VJ Craig","year":"2015","unstructured":"Craig VJ, Zhang L, Hagood JS, Owen CA. Matrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol. 2015;53(5):585\u2013600.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"3414_CR43","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-078276","volume":"386","author":"O Efthimiou","year":"2024","unstructured":"Efthimiou O, Seo M, Chalkou K, Debray T, Egger M, Salanti G. Developing clinical prediction models: a step-by-step guide. BMJ. 2024;386:e078276.","journal-title":"BMJ"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-025-03414-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-025-03414-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-025-03414-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T12:46:47Z","timestamp":1764074807000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-025-03414-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3414"],"URL":"https:\/\/doi.org\/10.1186\/s12931-025-03414-3","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"7 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all patients. This study was approved by the Ethics Review Committee of the China-Japan Friendship Hospital (approval number: 2022-KY-156).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"329"}}